Press Release

Thrombin Market 2020 Growth Analysis, Global Trend, Segmentation and Forecast till 2025

Thrombin Market Summarized details by key players Pfizer Inc., Johnson & Johnson, Services Inc., Baxter, Shanghai RAAS blood products co. Ltd., Japan Blood Products Organization, Mochida Pharmaceutical Co. Other prominent players

The Global Thrombin Market is supported by the rising rate of thrombosis among individuals, all around. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.”

In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market, and it is estimated to expand at a CAGR of 4.1%. As of 2018, The Global Thrombin Market has valued at US$ 535.0 Mn, and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Some of the Main Key Players Covered in the Report:

  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Baxter
  • Shanghai RAAS blood products co. Ltd.
  • Japan Blood Products Organization

Get Sample PDF [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/thrombin-market-100170

Widespread Applications of Thrombin to Boost Global Market

The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derive thrombin in the coming years.

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.

SECONDARY DATA SOURCES THAT WE REFER TO:

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

Key Segmentation:

By Product

  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin

By Dosage Form

  • Powder Form
  • Solution Form

By End user

  • Hospitals
  • Diagnostics Centers & Clinics
  • Academics and Research Institutes

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

More Trending Topics from Fortune Business Insights:

E-prescribing Market Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026

Compression Therapy Market Research Report 2020: Global Industry Analysis, Business Development, Size, Share, Trends, Future Growth, Forecast To 2026

Anticoagulants Market by Top Key Players are Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., Eisai Co., Ltd.

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close